Shih-Ying Chang

This profile gathers the share dealings of Shih-Ying Chang in 迪哲医药, where the filings describe the role as senior executive. We count 4 filings; the first trade dates from 25 June 2025 and the latest from 21 August 2025.

Market trades split into 1 purchase (€1,972) and 3 sales (€102k). The net balance comes to €100k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The newest entry dates from 21 August 2025: an open-market purchase of €1,972, in 迪哲医药. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.